You are here: Home » Current Affairs » News » National
Business Standard

Modi chairs review meeting of Covid research, vaccine deployment ecosystem

PM Modi held a review meeting of the research and vaccine deployment ecosystem against the Covid-19 pandemic including testing technologies, contact tracing, drugs and therapeutics, etc

Topics
Coronavirus Vaccine | Narendra Modi | Coronavirus

ANI  |  General News 

Narendra Modi
Prime Minister Narendra Modi

Prime Minister on Thursday held a review meeting of the research and vaccine deployment ecosystem against the COVID-19 pandemic including testing technologies, contact tracing, drugs and therapeutics, etc.

The meeting was attended by Union Health Minister Harsh Vardhan; Member (Health), NITI Aayog; Principal Scientific Advisor; senior scientists; and other officials.

The Prime Minister appreciated the efforts made by Indian vaccine developers and manufacturers to rise to the COVID-19 challenge and committed to continue government facilitation and support for all such efforts.

Prime Minister Modi stated that regulatory reform was a dynamic process, and experts in every current and emerging domain should be used by the regulator proactively, as many new approaches have emerged.

The Prime Minister took stock of the Health Ministry's comprehensive distribution and delivery mechanism for vaccines. This includes mechanisms for adequate procurement, and technologies for bulk-stockpiling, filling vials for distribution and ensuring effective delivery.

He directed that both serosurveys and testing must be scaled up. He said that the facility to get tested regularly, speedily and inexpensively must be available to all at the earliest.

PM Modi also underscored the need for continuous and rigorous scientific testing and validation of traditional medical treatments. He appreciated the efforts of the Ministry of AYUSH for conducting evidence-based research and providing a reliable solution in this difficult time.

The Prime Minister reiterated the country's resolve to provide cost-effective, easily available and scalable solutions for testing, vaccine and medication, not only for India but for the entire world.

He called for continued vigilance and a high state of preparedness against the pandemic.

(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)

Dear Reader,


Business Standard has always strived hard to provide up-to-date information and commentary on developments that are of interest to you and have wider political and economic implications for the country and the world. Your encouragement and constant feedback on how to improve our offering have only made our resolve and commitment to these ideals stronger. Even during these difficult times arising out of Covid-19, we continue to remain committed to keeping you informed and updated with credible news, authoritative views and incisive commentary on topical issues of relevance.
We, however, have a request.

As we battle the economic impact of the pandemic, we need your support even more, so that we can continue to offer you more quality content. Our subscription model has seen an encouraging response from many of you, who have subscribed to our online content. More subscription to our online content can only help us achieve the goals of offering you even better and more relevant content. We believe in free, fair and credible journalism. Your support through more subscriptions can help us practise the journalism to which we are committed.

Support quality journalism and subscribe to Business Standard.

Digital Editor

First Published: Thu, October 15 2020. 20:45 IST
RECOMMENDED FOR YOU
.